newsfilter
← Latest News
PR Newswire·

Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a biopharmaceutical company with three clinical programs in development and a strong...